Prenetics Global (PRE) Cash from Financing Activities (2025 - 2026)

Prenetics Global (PRE) posted quarterly Cash from Financing Activities of -$13.3 million for Q1 2026, down 1820.12% year-over-year from $771343.4 in Q1 2025, and down 134.53% quarter-over-quarter from $38.4 million in Q4 2025.

Prenetics Global (PRE) Cash from Financing Activities (2025 - 2026) Analysis & Trends

Prenetics Global (PRE) has reported Cash from Financing Activities for 2 consecutive years, with -$13.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 1820.12% year-over-year to -$13.3 million; the TTM figure through Mar 2026 stood at $23.8 million (changed N/A YoY), while the FY2025 annual figure was $37.5 million, up 1220.76% from the prior year.
  • Cash from Financing Activities slipped to -$13.3 million in Q1 2026 per PRE's latest filing, from $38.4 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $38.4 million in Q4 2025 and bottomed at -$13.3 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn -1.57 Bn
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn 7.27 Bn
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn -325.19 Mn
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn -144.00 Mn
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn -214.00 Mn
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn 3.76 Mn
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn -129.00 Mn
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn -317.75 Mn
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn -229.00 Mn
10 Prenetics Global 306.55 Mn 200.52 Mn 23.28 Mn -13.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.27 Mn
Mar 31, 2026 -13.27 Mn
Dec 31, 2025 38.43 Mn
Dec 31, 2025 38.43 Mn
Jun 30, 2025 -660,000.00
Jun 30, 2025 -660,000.00
Mar 31, 2025 -691,000.00
Mar 31, 2025 -691,000.00